Author(s)

Hicham Benyoussef^1,2, Said Makani^1,2, Mohammed Yassine Benzha^1,2, Amal Haoudar^1,3, Aziza Kantri^1,3, Chafik El Kettani Hamidi^1,3, Soukaina Scadi^1,4, Amal El Ouradi^1,4, Mohamed Sabry^1,4, Mahdi Ait Houssa^5,6

¹Mohammed VI University of Health Sciences, Casablanca, Morocco.
²Cardiac and Vascular Surgery Department, International University Hospital Cheikh Khalifa Ibn Zaid, Casablanca, Morocco.
³Cardiac and Vascular Anesthesia and Intensive Care Department, International University Hospital Cheikh Khalifa Ibn Zaid, Casa-blanca, Morocco.
⁴Cardiology Department, International University Hospital Cheikh Khalifa Ibn Zaid, Casablanca, Morocco.
⁵Cardiovascular Surgery Department of Military Hospital, Rabat, Morocco.
⁶Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco.

Background: The aim of this study was to evaluate the impact of additional coronary revascularization on the early results in patients submitted to valve surgery. Patients and Methods: A retrospective review of the cardiac surgical database between January 2000 and December 2018 was performed. A total of 1667 patients were included and divided into two groups: Group A isolated valve surgery (IVS n = 1608) and Group B with valve surgery combined to coronary artery bypass grafting (VS + CABG n = 59). Demographic, operative data and postoperative outcomes were compared between groups. Results: Patients with combined procedure were older than patients who underwent isolated valvular surgery (64.9 ± 9.2 years vs 44.4 ± 13.1 years; p = 0.0001) and there was a higher proportion of diabetics (40.7% vs 6.6%; p = 0.0001). The 30 days mortality rate in the combined procedure group was 18.6% versus 6.2% in isolated valve surgery (p = 0.001). Also post-operative complications were more frequent than for patients who underwent IVS. Additionally we noted a high prevalence of coronary artery risk factors in patients with combined procedures. Conclusion: Surgical mortality and morbidity of coexisting coronary and heart valve disease were substantially higher than IVS. More efforts in medical management may reduce the incidence of adverse outcomes.

Valvular Disease, Coronary Artery Disease, Coronary Artery Bypass Grafting

Benyoussef, H. , Makani, S. , Benzha, M. , Haoudar, A. , Kantri, A. , Hamidi, C. , Scadi, S. , El Ouradi, A. , Sabry, M. and Houssa, M. (2019) Does Additional Coronary Artery Bypass Grafting Increase Hospital Mortality of Patients Requiring Valve Surgery?. World Journal of Cardiovascular Surgery, 9, 143-154. doi: 10.4236/wjcs.2019.910016.